Skip to main content

Beyond Air, Inc. (XAIR) Stock Forecast

Data as of Sep 21, 2026

Healthcare · Current price $3.19 (+3.57%)

Consensus Target
$10.00
Upside
+213.5%
Analysts
1
Rating
Buy(2.00)

Price Target Range

Low $10.00High $10.00

Consensus Price Target Over Time

Analyst Rating Distribution

Last 3 Months

No ratings in the last 3 months.
Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0

6-Month Trend

No rating trend data.

Latest Analyst Forecasts

Price targets issued by Wall Street analysts. Upside calculated against today's price.

No analyst price targets available.

XAIR vs Sector & Market

MetricXAIRHealthcare AvgLarge Cap Avg
Analyst Rating2.002.262.42
Analyst Count1818
Target Upside+213.5%+22243.5%+21.5%
P/E Ratio-0.143.7638.34

Revenue Estimates

PeriodLowAvgHigh#
2027-03-31$12M$13M$13M3
2028-03-31$29M$29M$29M2
2029-03-31$59M$61M$62M1
2030-03-31$74M$76M$78M1

EPS Estimates

PeriodLowAvgHigh#
2027-03-31$-1.80$-1.75$-1.702
2028-03-31$-2.17$-1.56$-0.962
2029-03-31$-0.56$-0.55$-0.541
2030-03-31$-0.44$-0.43$-0.421

Frequently Asked Questions

What is the analyst consensus for XAIR?

The consensus among 1 analysts covering Beyond Air, Inc. (XAIR) is Buy with an average price target of $10.00.

What is the highest price target for XAIR?

The highest analyst price target for XAIR is $10.00.

What is the lowest price target for XAIR?

The lowest analyst price target for XAIR is $10.00.

How many analysts cover XAIR?

1 analysts have issued ratings for Beyond Air, Inc. in the past 12 months.

Is XAIR a buy or sell right now?

Based on 1 analyst ratings, XAIR has a consensus rating of Buy (2.00/5) with a +213.5% upside to the consensus target of $10.00.

What are the earnings estimates for XAIR?

Analysts estimate XAIR will report EPS of $-1.75 for the period ending 2027-03-31, with revenue estimated at $13M.

Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.